Indirect Pathway Metabolic Engineering Strategies for Enhanced Biosynthesis of Hyaluronic Acid in Engineered
Overview
Affiliations
Hyaluronic acid (HA) is composed of alternating d-glucuronic acid and -acetyl-d-glucosamine, with excellent biocompatibility and water retention capacity. To achieve heterologous biosynthesis of HA, , a safe GRAS (generally recognized as safe) host, was utilized and metabolically engineered previously. In this work, to achieve further enhancement of HA yield, four strategies were proposed and performed separately first, i.e., (1) improvement of glucose uptake via gene knockout, releasing the inhibition of transporter IolT1/IolT2 and glucokinases; (2) intensification of cardiolipin synthesis through overexpression of genes // involved in cardiolipin synthesis; (3) duly expressed hemoglobin in genome, enhancing HA titer coupled with more ATP and improved NAD/NADH (>7.5) ratio; and (4) identification of the importance of glutamine for HA synthesis through transcriptome analyses and then enhancement of the HA titer via its supplement. After that, we combined different strategies together to further increase the HA titer. As a result, one of the optimal recombinant strains, Cg-dR-CLS, yielded 32 g/L of HA at 60 h in a fed-batch culture, which was increased by 30% compared with that of the starting strain. This high value of HA titer will enable the industrial production of HA via the engineered .
Hu L, Xiao S, Sun J, Wang F, Yin G, Xu W Nat Commun. 2025; 16(1):2076.
PMID: 40021631 PMC: 11871322. DOI: 10.1038/s41467-025-56950-3.
Yuan S, Zheng Y, Du Y, Song M, Sun C, Cheng F Biotechnol Notes. 2024; 4:135-145.
PMID: 39416921 PMC: 11446395. DOI: 10.1016/j.biotno.2023.12.003.
Afrasiabi S, Zanjani F, Ahmadian G, Cohan R, Keramati M AMB Express. 2023; 13(1):63.
PMID: 37354246 PMC: 10290625. DOI: 10.1186/s13568-023-01567-2.
Prospective bacterial and fungal sources of hyaluronic acid: A review.
Shikina E, Kovalevsky R, Shirkovskaya A, Toukach P Comput Struct Biotechnol J. 2022; 20:6214-6236.
PMID: 36420162 PMC: 9676211. DOI: 10.1016/j.csbj.2022.11.013.
Li N, Shan X, Zhou J, Yu S Front Bioeng Biotechnol. 2022; 10:978686.
PMID: 36185436 PMC: 9515461. DOI: 10.3389/fbioe.2022.978686.